Pharmacopeia
CWP-0202
PHENYLZINE MAO-I
Neurology & Sedation · Neurology & Sedation · Level 3
Core pharmacology
- Class Group
Antidepressant - Monoamine oxidase inhibitors
- Legacy Cicm Level
Level 3
- Mechanism of action
Irreversible MAO A and B inhibition leading to accumulation of:
1. Noradrenaline
2. Serotonin
Dopamine- Adverse Effects Toxicity
1. Serotonin
2. Histamine
3. Anticholinergic
4. Anti-alpha
5. AdrenergicInteracts with other antidepressants, foods high in tyramine (cheese) and sympathomimetic
- Absorption
Incomplete data available
- Distribution
Incomplete data available
- Metabolism
Incomplete data available
- Excretion
Renal elimination of metabolites
- Half-life
Duration depends on time taken for MAO synthesis